Arylfurans as potential Trypanosoma cruzi trypanothione reductase inhibitors

被引:37
|
作者
de Oliveira, RB
Vaz, ABM
Alves, RO
Liarte, DB
Donnici, CL
Romanha, AJ
Zani, CL
机构
[1] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Quim Prod Nat, BR-30190002 Belo Horizonte, MG, Brazil
[2] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Parasitol Celular & Mol, BR-30190002 Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Inst Ciencias Exatas, NEQUIM, Dept Quim, Belo Horizonte, MG, Brazil
来源
MEMORIAS DO INSTITUTO OSWALDO CRUZ | 2006年 / 101卷 / 02期
关键词
tropical diseases; Chagas disease; arylfurans; trypanothione reductase;
D O I
10.1590/S0074-02762006000200009
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The natural lignans veraguensin and grandisin have been reported to be active against Trypanosoma cruzi bloodstream forms. Aiming at the total synthesis of these and related compounds, we prepared three 2-arylfurans and eight 2,5-diary rans. They were evaluated for their potential as T. cruzi trypanothione reductase (TR) inhibitors as well against the parasite intracellular (amastigote) and bloodstream (trypomastigote) forms. Compound 12 was the most effective against TR with an IC50 of 48.5 mu M while 7 and 14 were active against amastigotes, inhibiting the parasite development by 60% at 20 mu g/ml (59 and 90 mu M, respectively). On the other hand, none of the compounds was significantly active against the parasite bloodstream forms even at 250 mu g/ml (0.6-1.5 mM).
引用
收藏
页码:169 / 173
页数:5
相关论文
共 50 条
  • [41] Inhibition of Trypanosoma cruzi trypanothione reductase by novel dibenzosuberyl-spermidine analogs.
    Kobaslija, M
    O'Sullivan, MC
    Durham, T
    Bacchi, CJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U405 - U405
  • [42] Trypanothione reductase inhibitors
    Edwards, P
    DRUG DISCOVERY TODAY, 2001, 6 (01) : 54 - 54
  • [43] Trypanosoma cruzi trypanothione reductase is inactivated by peroxidase-generated phenothiazine cationic radicals
    Gutierrez-Correa, J
    Fairlamb, AH
    Stoppani, AOM
    FREE RADICAL RESEARCH, 2001, 34 (04) : 363 - 378
  • [44] Docking-based screening of natural product database in quest for dual site inhibitors of Trypanosoma cruzi trypanothione reductase (TcTR)
    Saha, Debasmita
    Sharma, Anuj
    MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (01) : 316 - 333
  • [45] Docking-based screening of natural product database in quest for dual site inhibitors of Trypanosoma cruzi trypanothione reductase (TcTR)
    Debasmita Saha
    Anuj Sharma
    Medicinal Chemistry Research, 2015, 24 : 316 - 333
  • [46] Inhibition of Trypanosoma cruzi trypanothione reductase by acridines:: Kinetic studies and structure-activity relationships
    Bonse, S
    Santelli-Rouvier, C
    Barbe, J
    Krauth-Siegel, RL
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (26) : 5448 - 5454
  • [47] Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T-cruzi
    Jones, Deuan C.
    Ariza, Antonio
    Chow, Wing-Huen A.
    Oza, Sandra L.
    Fairlamb, Alan H.
    MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2010, 169 (01) : 12 - 19
  • [48] The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 angstrom resolution
    Zhang, YH
    Bond, CS
    Bailey, S
    Cunningham, ML
    Fairlamb, AH
    Hunter, WN
    PROTEIN SCIENCE, 1996, 5 (01) : 52 - 61
  • [49] TRYPANOSOMA-CRUZI TRYPANOTHIONE REDUCTASE - CRYSTALLIZATION, UNIT-CELL DIMENSIONS AND STRUCTURE SOLUTION
    ZHANG, YH
    BAILEY, S
    NAISMITH, JH
    BOND, CS
    HABASH, J
    MCLAUGHLIN, P
    PAPIZ, MZ
    BORGES, A
    CUNNINGHAM, M
    FAIRLAMB, AH
    HUNTER, WN
    JOURNAL OF MOLECULAR BIOLOGY, 1993, 232 (04) : 1217 - 1220
  • [50] New Amino Naphthoquinone Derivatives as Anti-Trypanosoma cruzi Agents Targeting Trypanothione Reductase
    Espinosa-Bustos, Christian
    Ortiz Perez, Mariana
    Gonzalez-Gonzalez, Alonzo
    Zarate, Ana Maria
    Rivera, Gildardo
    Belmont-Diaz, Javier A.
    Saavedra, Emma
    Cuellar, Mauricio A.
    Vazquez, Karina
    Salas, Cristian O.
    PHARMACEUTICS, 2022, 14 (06)